Price$10.30+0.13 (+1.28%)
01:30 PM07:45 PM
News · 26 weeks41-75%
2025-12-142026-06-07
Mix1390d
- SEC Filings4(31%)
- Other3(23%)
- Insider3(23%)
- Earnings2(15%)
- Market1(8%)
Latest news
25 items- PRVarex to Present at the Jefferies Global Healthcare ConferenceVarex Imaging Corporation (NASDAQ:VREX) announced today that management is scheduled to present at the Jefferies Global Healthcare Conference in New York. Management will participate in a fireside chat presentation on Wednesday, June 3, 2026 at 3:10 pm ET. The presentation will be webcast and can be accessed here or on Varex's website at www.vareximaging.com/news. About Varex Varex Imaging Corporation is a leading innovator, designer, and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors, and other image processing solutions that are key components of X-ray imaging systems, as well as X-ray imaging systems for industrial applications. With a 70+ ye
- SECSEC Form 10-Q filed by Varex Imaging Corporation10-Q - Varex Imaging Corp (0001681622) (Filer)
- SECVarex Imaging Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Varex Imaging Corp (0001681622) (Filer)
- PRVarex Announces Financial Results for Second Quarter Fiscal Year 2026Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the second quarter fiscal year 2026. Q2FY26 Summary Revenues $216 million GAAP gross margin 34% | Non-GAAP gross margin* 34% GAAP operating margin 7% | Non-GAAP operating margin* 9% GAAP net loss $0.19 per diluted share | Non-GAAP net income* $0.21 per diluted share Cash outflows from operations of $2 million "Demand remained solid in the second quarter, with continued momentum across both our Medical and Industrial businesses driven by global CT, cargo systems and photon counting detectors," said Sunny Sanyal, Chief Executive Officer. Sanyal added, "As we move into the second hal
- PRVarex Schedules Second Quarter Fiscal Year 2026 Earnings Release and Conference CallVarex Imaging Corporation (NASDAQ:VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2026, following the close of regular trading on Thursday, May 7, 2026. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company's website and a replay of the call will be available from May 7th through May
- INSIDERSEC Form 3 filed by new insider Merkley Jesse Don3 - Varex Imaging Corp (0001681622) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Varex Imaging CorporationSCHEDULE 13G/A - Varex Imaging Corp (0001681622) (Subject)
- INSIDERSEC Form 3 filed by new insider Garcia Victor Hugo3 - Varex Imaging Corp (0001681622) (Issuer)
- INSIDERSEC Form 4 filed by Kunkel Jay K.4 - Varex Imaging Corp (0001681622) (Issuer)
- SECSEC Form 144 filed by Varex Imaging Corporation144 - Varex Imaging Corp (0001681622) (Subject)
- NEWSSidoti Events, LLC's March Small-Cap Virtual ConferenceNEW YORK, NY / ACCESS Newswire / March 18, 2026 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day March Small-Cap Virtual Investor Conference taking place Wednesday and Thursday, March 18-19, 2026. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.Presentation Schedule*All Times EDTWednesday, March 18, 2026 (Day 1)9:15-9:45Braiin Limited (BRAI)*****TRX Gold Corporation (TRX)10:00-10:30Charles River Associates (CRAI)Mtron Industries, Inc (MPTI)Alpha Tau (DRTS)10:45-11:15IBEX Limited (IBEX)USANA Health Sciences (USNA)Magnera Corporation
- SECVarex Imaging Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits8-K - Varex Imaging Corp (0001681622) (Filer)
- PRVarex Announces Successful Completion of Debt RefinancingVarex Imaging Corporation (NASDAQ:VREX) today announced it has entered into a Credit and Guaranty Agreement (the "Credit Agreement"), dated as of March 13, 2026, which includes a secured term loan facility in aggregate principal amount of $350 million, a secured revolving credit facility in aggregate principal amount of $100 million and a secured delayed draw term loan facility in aggregate principal amount of $40 million (collectively, the "Credit Facility"), providing for aggregate commitments of $490 million and maturing on March 13, 2031. Zions Bancorporation, N.A. ("Zions") acted as lead arranger and bookrunner for the new Credit Facility and will act as the administrative agent and co
- PRVarex Management to Present in Upcoming Investor ConferencesVarex Imaging Corporation (NASDAQ:VREX) announced today that management is scheduled to present at the following upcoming investor conferences. Oppenheimer's 36th Annual Healthcare, MedTech & Services Virtual Conference: Tuesday, March 17, 2025 at 10:40am ET. Webcast link here. Sidoti Small Cap Virtual Conference: Wednesday, March 18, 2026 at 1:00pm ET. Webcast link here. The webcast can be accessed at the above links or on Varex's website at http://www.vareximaging.com/news. About Varex Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that
- PRVarex Imaging Corporation to Redeem Its 7.875% Senior Secured Notes Due 2027Varex Imaging Corporation (NASDAQ:VREX) (the "Company" or "Varex") today announced it has issued a notice of conditional full redemption of all of its outstanding 7.875% senior secured notes due October 15, 2027 (the "Notes") on March 16, 2026 (the "Redemption Date"). The aggregate principal amount of the outstanding Notes is $368,000,000. The redemption price for the Notes will be equal to 101.969% of the principal amount of the Notes, together with accrued and unpaid interest on the Notes to, but not including the Redemption Date, for a total payment to holders of $1,052.72125 per $1,000 principal amount of the Notes. The Company intends to fund the redemption of the Notes with pr
- SECVarex Imaging Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Varex Imaging Corp (0001681622) (Filer)
- INSIDERSEC Form 4 filed by Director Kunkel Jay K.4 - Varex Imaging Corp (0001681622) (Issuer)
- INSIDERSEC Form 4 filed by Director Bardwell Kathleen4 - Varex Imaging Corp (0001681622) (Issuer)
- INSIDERSEC Form 4 filed by Director Tsingos Christine A4 - Varex Imaging Corp (0001681622) (Issuer)
- INSIDERSEC Form 4 filed by Director Rosebrough Walter M Jr4 - Varex Imaging Corp (0001681622) (Issuer)
- INSIDERSEC Form 4 filed by Director Guertin Timothy E4 - Varex Imaging Corp (0001681622) (Issuer)
- INSIDERSEC Form 4 filed by Director Chertoff Jocelyn D4 - Varex Imaging Corp (0001681622) (Issuer)
- SECSEC Form 10-Q filed by Varex Imaging Corporation10-Q - Varex Imaging Corp (0001681622) (Filer)
- SECVarex Imaging Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Varex Imaging Corp (0001681622) (Filer)
- PRVarex Announces Financial Results for First Quarter Fiscal Year 2026Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the first quarter fiscal year 2026. Q1FY26 Summary Revenues $210 million GAAP gross margin 33% | Non-GAAP gross margin* 34% GAAP operating margin 7% | Non-GAAP operating margin* 9% GAAP net income $0.05 per diluted share | Non-GAAP net income* $0.19 per diluted share Cash outflow from operations of $16 million "We are pleased to report a solid start to fiscal 2026, with results toward the high-end of guidance. First quarter revenue of $210 million, increased 5% year-over-year. Growth in the quarter was driven by strength in our cargo systems business, which contributed to a 17% ye
VREX FAQ
6 questionsWhat does Varex Imaging Corporation do?
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys (a component of X-ray units that holds X-ray film cassettes). This segment's products are...Where does VREX stock trade?
Varex Imaging Corporation (VREX) is listed on NASDAQ.What sector and industry is VREX in?
Varex Imaging Corporation operates in the Technology sector, Industrial Machinery/Components industry.What are analysts saying about VREX?
Varex Imaging Corporation has had 2 recent analyst actions on file. The most recent action was from B. Riley Securities: Buy with a $2100.00 price target on 2024-08-23. Recent price targets range from $2100.00 to $2400.00.What companies are similar to VREX?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), ETN (Eaton Corporation PLC), DE (Deere & Company). Compare VREX side-by-side with any of them on Quantisnow.How can I track VREX on Quantisnow?
Quantisnow aggregates Varex Imaging Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow VREX to receive live email and push alerts on every new disclosure.